RICHARD F. WALLMAN - 11 May 2022 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Richard F. Wallman
Issuer symbol
CRL
Transactions as of
11 May 2022
Net transactions value
+$351,694
Form type
4
Filing time
13 May 2022, 16:44:50 UTC
Previous filing
06 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +575 +3.3% $0.000000 18,254 11 May 2022 Direct F1
transaction CRL Common Stock Award $0 +360 +2% $0.000000 18,614 11 May 2022 Direct F2
holding CRL Common Stock 0 11 May 2022 By Wife

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $351,694 +1,582 $222.31 1,582 11 May 2022 Common Stock 1,582 $222.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.
F2 The grant was made in lieu of director service fees for the term commencing May 10, 2022. The restricted stock units vest upon the earlier of 5/11/2023, or the business day prior to the Company's next annual meeting of shareholders.
F3 The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders.